Global Radiopharmaceutical Market – Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and Other Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global radiopharmaceutical Market to reach USD 7.13 billion in 2021, growing at a CAGR of 8.8% during 2016-2021.

The report covers forecast and analysis for the radiopharmaceutical market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million) and volume. The study includes drivers and restraints for the radiopharmaceutical along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the radiopharmaceutical market on a global level.

In order to give the users of this report a comprehensive view on the radiopharmaceutical market, we have included a detailed segmentation of radiopharmaceutical. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the radiopharmaceutical market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the radiopharmaceutical market by segmenting the market based on type and application. Diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals are the type segment of Radiopharmaceuticals market. Cardiology, neurology, oncology and other are the key application segment of radiopharmaceutical market. All the application segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.

Some of the major players in the radiopharmaceuticals market include Cardinal Health, Inc., GE Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A., Bayer Healthcare, Lantheus Medical Imaging, Inc., IBA Molecular Imaging, Mallinckrodt plc, Jubilant Pharma, and Siemens Healthcare.

The report segments the global radiopharmaceuticals market as:

Radiopharmaceuticals Market: Type Segment Analysis

  • Diagnostic Radiopharmaceuticals
    • SPECT
    • PET
  • Therapeutic radiopharmaceuticals
    • Beta emitters
    • Alpha emitters
    • Brachytherapy isotopes

Radiopharmaceuticals Market: Application Segment Analysis

  • Cardiology
  • Neurology
  • Oncology
  • Other

Radiopharmaceuticals Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
Table of Contents
  • Chapter 1. Preface
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Radiopharmaceutical Market, 2015 – 2021, (USD Billion)
    • 2.2. Radiopharmaceutical : Market snapshot
  • Chapter 3. Radiopharmaceutical Market: Industry Analysis
    • 3.1. Radiopharmaceutical : Market dynamics
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Growing demand for PET and SPECT radioisotopes
      • 3.3.2. Increasing incidences of cancer and heart diseases
    • 3.4. Restraints
      • 3.4.1. Stringent regulatory guidelines
      • 3.4.2. Shorter half-life of nuclear medicine
    • 3.5. Opportunity
      • 3.5.1. Advancing technologies and ongoing research
    • 3.6. Porter’s Five Forces Analysis
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market attractiveness analysis by type segment
      • 3.7.2. Market attractiveness analysis by application segment
      • 3.7.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Radiopharmaceutical Market: Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global radiopharmaceutical market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Product Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global Radiopharmaceutical Market: Product Overview
    • 5.1. Global radiopharmaceutical market share, by type, 2015 and 2021
    • 5.2. Global diagnostic radiopharmaceutical market, 2015 – 2021 (USD Billion)
    • 5.3. Global therapeutic radiopharmaceutical market, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Radiopharmaceutical Market: Application Overview
    • 6.1. Global radiopharmaceutical market share, by application, 2015 and 2021
    • 6.2. Global radiopharmaceutical market for cardiology, 2015 – 2021 (USD Billion)
    • 6.3. Global radiopharmaceutical market for neurology, 2015 – 2021 (USD Billion)
    • 6.4. Global radiopharmaceutical market for oncology, 2015 – 2021 (USD Billion)
    • 6.5. Global radiopharmaceutical market for other, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Radiopharmaceutical Market: Regional Analysis
    • 7.1. Global radiopharmaceutical market: Regional overview
      • 7.1.1. Global radiopharmaceutical market share, by region, 2015 and 2021
    • 7.2. North America
      • 7.2.1. North America radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.2.2. North America radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.2.3.2. U.S. radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.3.2. Europe radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.3.3. UK
        • 7.3.3.1. UK radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.3.3.2. UK radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.3.4.2. France radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.3.5. Germany
        • 7.3.5.1. Germany radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.3.5.2. Germany radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia-Pacific radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.4.2. Asia-Pacific radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.3.2. China radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.4.2. Japan radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.5.2. India radiopharmaceutical market revenue, by technology, 2015 – 2021 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.5.2. Latin America radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.5.3.2. Brazil radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East & Africa radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Cardinal Health, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. GE Healthcare
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Bracco Imaging S.p.A
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Nordion, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
      • 8.5. Advanced Accelerator Applications S.A.
    • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Bayer Healthcare
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Lantheus Medical Imaging, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
  • Chapter 9. Patents
    • 9.1. U.S. (US Patents)
    • 9.2. Europe (EP documents)
    • 9.3. Japan (Abstracts of Japan)
    • 9.4. Global (WIPO (PCT))

List of Figures

1. Global radiopharmaceutical  market segmentation by type, application, and geography
2. Global radiopharmaceutical  market, 2015 – 2021 (USD Billion)
3. Value chain analysis: Radiopharmaceutical  market
4. Porter’s five forces analysis: Radiopharmaceutical  market
5. Market attractiveness analysis by type segment
6. Market attractiveness analysis by application segment
7. Market attractiveness analysis by regional segment
8. Global Radiopharmaceutical  Market : Company Market Share, 2015
9. Price Trend Analysis : Radiopharmaceutical
10. Patent trend between 2011 -2016
11. Patent Share by Company between 2011 – 2016
12. Patent Share by Region between 2011 – 2016
13. Global radiopharmaceutical  market share, by type, 2015 -2021
14. Global diagnostic radiopharmaceutical  market, 2015 – 2021(USD Billion)
15. Global therapeutic radiopharmaceutical  market, 2015 – 2021 (USD Billion)
16. Global radiopharmaceutical  market share, by application, 2015 -2021
17. Global radiopharmaceutical  market for cardiology, 2015 – 2021 (USD Billion)
18. Global radiopharmaceutical  market for oncology, 2015 – 2021 (USD Billion)
19. Global radiopharmaceutical  market for neurology, 2015 – 2021(USD Billion)
20. Global radiopharmaceutical  market for others, 2015 – 2021 (USD Billion)
21. Global radiopharmaceutical  market share, by region, 2015 – 2021
22. North America radiopharmaceutical  market, 2015 – 2021, (USD Billion)
23. U.S. radiopharmaceutical  market, 2015 – 2021,  (USD Billion)
24. Europe radiopharmaceutical  market, 2015 – 2021, (USD Billion)
25. UK radiopharmaceutical  market, 2015 – 2021, (USD Billion)
26. France radiopharmaceutical  market, 2015 – 2021,  (USD Billion)
27. Germany radiopharmaceutical  market, 2015 – 2021, (USD Billion)
28. Asia Pacific radiopharmaceutical  market, 2015 – 2021, (USD Billion)
29. China radiopharmaceutical  market, 2015 – 2021,  (USD Billion)
30. Japan radiopharmaceutical  market, 2015 – 2021,  (USD Billion)
31. India radiopharmaceutical  market, 2015 – 2021, (USD Billion)
32. Latin America radiopharmaceutical  market, 2015-2021,  (USD Billion)
33. Brazil radiopharmaceutical  market, 2015 – 2021,  (USD Billion)
34. Middle East & Africa radiopharmaceutical  market, 2015 – 2021, (USD Billion)


List of Tables

1. Global radiopharmaceutical  market snapshot
2. Drivers for radiopharmaceutical  market: Impact analysis
3. Restraints of radiopharmaceutical  market: Impact analysis
4. North America radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
5. North America radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
6. U.S. radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
7. U.S. radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
8. Europe radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
9. Europe radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
10. UK radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
11. UK radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
12. France radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
13. France radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
14. Germany radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
15. Germany radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
16. Asia-Pacific radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
17. Asia-Pacific radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
18. China radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
19. China radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
20. Japan radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
21. Japan radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
22. India radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
23. India radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
24. Latin America radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
25. Latin America radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
26. Brazil radiopharmaceutical  market revenue, by type, 2015 – 2021 (USD Billion)
27. Brazil radiopharmaceutical  market revenue, by application, 2015 – 2021 (USD Billion)
28. Middle East & Africa radiopharmaceutical market revenue, by type, 2015 – 2021 (USD Billion)
29. Middle East & Africa radiopharmaceutical market revenue, by application, 2015 – 2021 (USD Billion)

Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?

Prove You are Human (required)

captcha
Enter Capcha Image Properly